Form 4: Phreesia SVP, Life Sciences, David Linetsky, Disposes of Shares to Cover Tax Obligations

David Linetsky, SVP of Life Sciences at Phreesia, Inc., sold 1,946 shares of common stock to cover tax obligations related to a restricted stock unit settlement.

Summary

• David Linetsky, Senior Vice President of Life Sciences at Phreesia, Inc., disposed of 1,946 shares of common stock on January 15, 2025.
• The shares were sold at a weighted average price of $26.9813 per share.
• The sale was conducted to cover tax withholding obligations related to the settlement of a restricted stock unit award.
• The transactions were non-discretionary and executed under the company's mandatory sell-to-cover policy.
• Following the transaction, Mr. Linetsky directly owns 237,265 shares and indirectly owns 8,851 shares through his spouse.

Sentiment

Score: 5

Explanation: This is a neutral event, a routine transaction for tax purposes, and does not indicate any positive or negative sentiment about the company's performance.

Industry Context

This is a routine transaction for executives who receive stock-based compensation. It is common for companies to have a sell-to-cover policy to manage tax obligations.

Comparison to Industry Standards

• Sell-to-cover transactions are a standard practice among publicly traded companies to manage tax obligations for employees receiving stock-based compensation.
• The price range of $26.6905 to $27.38 per share is within the typical trading range for Phreesia stock at the time of the transaction.
• Similar transactions are regularly reported by executives at comparable companies in the technology and healthcare sectors.

Stakeholder Impact

• The transaction has a minimal impact on shareholders as it is a routine sale to cover tax obligations.

Key Dates

Keywords

Phreesia, insider trading, Form 4, stock sale, David Linetsky, restricted stock units, tax obligations, sell-to-cover